SRENYSEGas & Other Services CombinedFiscal year ends December 31Also trades as SREA
SEMPRA
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Aug 6, 2026
$81.74−1.67 (-2.00%)
Close on Oct 19, 2026
- Market cap
- $53.58B
- P/E (TTM)
- 27.7
- Dividend yield
- 3.16%
Margins
Share of revenue, fiscal years 2011 to 2025
Net margin
13.4%
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +3.9% | -1.7% | +3.8% | +3.0% | |
| Net income | -35.8% | -4.9% | – | +3.1% | |
| EPS, diluted | -37.8% | -6.0% | -15.6% | +0.2% | |
| Dividend per share | +4.0% | +4.1% | +4.3% | +6.3% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 11.1% | – | 5.8% | |
| Return on assets | 3.1% | – | 1.8% | |
| Current ratio | 0.52 | 0.66 | 1.59 | |
| Debt to equity | 1.32 | 1.04 | 1.11 | |
| Capex to revenue | 41.4% | 41.1% | 77.4% | |
| Diluted shares | 502M | 585M | 654M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Sempra generated $20.67B from operations and spent $45.89B on capital expenditure, dividends and share buybacks. 82% of that went back into the business.
Generated
$20.67B
Used
$45.89B
Capital expenditure$37.60B82%Dividends$7.35B16%Share buybacks$950.00M2%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin13.4%
×Asset turnover0.13×
×Equity multiplier3.30×
=Return on equity, FY20255.8%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 13.4% | 0.13× | 3.30× | 5.8% |
| FY2024 | 21.7% | 0.14× | 3.06× | 9.6% |
| FY2023 | 18.4% | 0.20× | 2.97× | 11.0% |
| FY2022 | 14.8% | 0.19× | 2.84× | 8.1% |
| FY2021 | 10.3% | 0.19× | 2.81× | 5.3% |
| FY2017 | 2.7% | 0.20× | 3.83× | 2.0% |
| FY2016 | 13.5% | 0.23× | 3.59× | 11.1% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
5of 8 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero$1.84B
- Cash generatingOperating cash flow above zero$4.57B
- Return on assets improvedROA up on the prior year3.3% → 1.9%
- Earnings backed by cashOperating cash flow above net income$4.57B vs $1.84B
- Less leverageLong-term debt to assets fell32.8% → 26.1%
- Better liquidityCurrent ratio rose0.55 → 1.59
- No dilutionShare count did not rise638M → 654M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose0.15 → 0.14